翰森制药(03692.HK)公布，GlaxoSmithKline「GSK」就GSK5764227(亦称HS-20093)获美国食品药品监督管理局「FDA」授予突破性疗法认定，此B7-H3靶向抗体药物偶联物正在评估用於治疗既往经二线及以上治疗进展的复发 ...

At GlaxoSmithKline, we never lose sight of the fact that patients are at the core of what we do and that millions of lives are impacted by cancer. The patient’s voice is at the heart of our ...

Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...